Literature DB >> 8472804

Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus.

M A Viviani1, A M Tortorano, G Rizzardini, T Quirino, L Kaufman, A A Padhye, L Ajello.   

Abstract

A case of disseminated penicilliosis marneffei, the first to be diagnosed in Italy, is described in a male HIV-positive drug addict. The patient had visited Thailand several times in the two years prior to his hospitalization. The presenting signs were fever, productive cough, facial skin papules and pustules, nodules on both thumbs and oropharyngeal candidiasis. Penicillium marneffei was isolated from a series of blood specimens with the lysis centrifugation procedure. Septate, yeast-like cells were observed in histological sections of the nodules and sputum smears. The patient was treated for 6 weeks with amphotericin B (total dosage 1,400 mg) and flucytosine (150 mg/kg/die) for the first 3 weeks. Prompt clinical improvement and sterilization of all biological specimens were attained. Itraconazole was administered as maintenance therapy (400 mg/die for the first month and 200 mg afterward). During the follow-up period, no relapse was observed. The patient, however, did succumb to a variety of non-mycotic infections and died nine months after start of therapy. At autopsy, P. marneffei was not detected in his tissues. Serological studies were performed with a micro-immunodiffusion procedure using a mycelial culture filtrate antigen of P. marneffei. Sera taken early in the course of the disease gave positive antibody reactions. Whereas sera taken 3-5 months following therapy were negative. All known cases of penicilliosis marneffei in bamboo rats and in humans among the inhabitants and visitors to the endemic areas of P. marneffei in South East Asia and Indonesia are summarized.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472804     DOI: 10.1007/bf00463094

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  Penicillium marneffei: another pathogen to consider in patients infected with human immunodeficiency virus.

Authors:  D N Tsang; P C Li; M S Tsui; Y T Lau; K F Ma; E K Yeoh
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

2.  Penicillium marneffei infection: a follow-up.

Authors:  A F DiSalvo
Journal:  Am J Clin Pathol       Date:  1989-04       Impact factor: 2.493

3.  Chronic lymphadenopathy caused by Penicillium marneffei: a condition mimicking tuberculous lymphadenopathy.

Authors:  W C Yuen; Y F Chan; S L Loke; W H Seto; G P Poon; K K Wong
Journal:  Br J Surg       Date:  1986-12       Impact factor: 6.939

4.  Penicillosis marneffei: serological and exoantigen studies.

Authors:  A S Sekhon; J S Li; A K Garg
Journal:  Mycopathologia       Date:  1982-01-15       Impact factor: 2.574

5.  Ultrastructural observations on Penicillium marneffei in natural human infection.

Authors:  Y F Chan; T C Chow
Journal:  Ultrastruct Pathol       Date:  1990 Sep-Oct       Impact factor: 1.094

Review 6.  Penicillium marneffei infection: an underdiagnosed disease?

Authors:  D N Tsang; J K Chan; Y T Lau; W Lim; C H Tse; N K Chan
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

7.  Human penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus).

Authors:  Z L Deng; M Yun; L Ajello
Journal:  J Med Vet Mycol       Date:  1986-10

8.  Penicillium marneffei osteomyelitis.

Authors:  Y F Chan; K C Woo
Journal:  J Bone Joint Surg Br       Date:  1990-05

Review 9.  Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus.

Authors:  T E Peto; R Bull; P R Millard; D W Mackenzie; C K Campbell; M E Haines; R G Mitchell
Journal:  J Infect       Date:  1988-05       Impact factor: 6.072

10.  Penicillium marneffei infection in patients infected with human immunodeficiency virus.

Authors:  K Supparatpinyo; S Chiewchanvit; P Hirunsri; C Uthammachai; K E Nelson; T Sirisanthana
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

View more
  15 in total

1.  Immunoreactivity of a 38-kilodalton Penicillium marneffei antigen with human immunodeficiency virus-positive sera.

Authors:  P Chongtrakool; S C Chaiyaroj; V Vithayasai; S Trawatcharegon; R Teanpaisan; S Kalnawakul; S Sirisinha
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient.

Authors:  Pingli Wang; Youfei Chen; Hao Xu; Liren Ding; Zuqun Wu; Zhijiang Xu; Kai Wang
Journal:  Mycopathologia       Date:  2017-03-27       Impact factor: 2.574

4.  Diagnostic antigenemia tests for penicilliosis marneffei.

Authors:  L Kaufman; P G Standard; M Jalbert; P Kantipong; K Limpakarnjanarat; T D Mastro
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

5.  Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene.

Authors:  Nongnuch Vanittanakom; Pramote Vanittanakom; Roderick J Hay
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

6.  Restriction endonuclease analysis of Penicillium marneffei.

Authors:  N Vanittanakom; C R Cooper; S Chariyalertsak; S Youngchim; K E Nelson; T Sirisanthana
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 7.  Update of Penicillosis marneffei in Thailand. Review article.

Authors:  P Imwidthaya
Journal:  Mycopathologia       Date:  1994-09       Impact factor: 2.574

8.  Pulmonary penicillosis marneffei: report of the first imported case in Canada.

Authors:  A S Sekhon; L Stein; A K Garg; W A Black; J D Glezos; C Wong
Journal:  Mycopathologia       Date:  1994-10       Impact factor: 2.574

Review 9.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Differential cytokine pattern in the spleens and livers of BALB/c mice infected with Penicillium marneffei: protective role of gamma interferon.

Authors:  Francesca Sisto; Annarita Miluzio; Orazio Leopardi; Maurizio Mirra; Johan R Boelaert; Donatella Taramelli
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.